Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  4, 222 - 227 (1998)
doi:10.1038/nm0298-222

Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease

Matthew J. Pollman1, Jennifer L. Hall2, Michael J. Mann2, Lunan Zhang2 & Gary H. Gibbons2, 3

  1Falk Cardiovascular Research Center, Division of Cardiovascular Medicine, Stanford University, 300 Pasteur Drive, Stanford, California 94305-5246, USA

  2Brigham and Women's Hospital, Thorn Cardiovascular Research Laboratories, 1326, 75 Francis Street, Boston, Massachusetts 02115, USA

  3e-mail: ggibbons@bustoff.bwh.harvard.edu

We postulated that activation of a genetic program that tonicaiiy inhibits intimal cell death is a necessary condition for the pathogenesis of vascular disease. Studies of vascular lesions in humans and animal models documented increased expression of the anti-apoptotic gene product Bcl-xL within intimal cells. Downregulation of intimal cell bcl-x L expression with the use of antisense oligonucleotides induced apoptosis and acute regression of vascular lesions. These findings indicate that apoptosis regulatory genes such as bcl-x L are critical determinants of intimal lesion formation and that targeted apoptosis may be a novel therapy for intimal vascular disease.

REFERENCES
  1. Han, D.K.M. et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147, 267−277 (1995). | PubMed  | ISI | ChemPort |
  2. Geng, Y.J. & Libby, P. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1 beta-converting enzyme. Am. J. Pathol. 147, 251−266 (1995). | PubMed  | ISI | ChemPort |
  3. Isner, J.M., Kearney, M., Bortman, S. & Passeri, J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91, 2703−2711 (1995). | PubMed  | ISI | ChemPort |
  4. Bochaton-Piallat, M.L., Gabbiani, F., Redard, M., Desmouliere, A. & Cabbiani, G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am. J. Pathol. 146, 1059−1064 (1995). | PubMed  | ChemPort |
  5. Perlman, H., Maillard, L., Krasinski, K. & Walsh, K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95, 981−987(1997). | PubMed  | ChemPort |
  6. Sedlak, T.W. et al. Multiple Bcl-2 family members demonstrate selective dimeriza-tionswith Bax. Proc. Natl. Acad. Sci. USA 92, 7834−7838 (1995). | PubMed  | ChemPort |
  7. Gajewski, T.F. & Thompson, C.B. Apoptosis meets signal transduction: Elimination of a BAD influence. Cell 87, 589−592 (1996). | Article | PubMed  | ISI | ChemPort |
  8. Golstein, P. Controlling cell death. Science 275, 1081 1082 (1997). | Article | PubMed  | ChemPort |
  9. Cheng, E.H., Levine, B., Boise, L.H., Thompson, C.B. & Hardwick, J.M. Bax-inde-pendent inhibition of apoptosis by Bcl-XL. Nature 379, 554−556 (1996). | Article | PubMed  | ISI | ChemPort |
  10. Zha, J. et al. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem. 272, 24101−24104 (1997). | Article | PubMed  | ISI | ChemPort |
  11. Chinnaiyan, A.M., O'Rourke, K., Lane, B.R. & Dixit, V.M. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275, 122−126 (1997). | Article |
  12. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science 267, 1506−1510 (1995). | PubMed  | ISI | ChemPort |
  13. Schwartz, S.M., deBlois, D. & O'Brien, E.R. The intima: Soil for atherosclerosis and restenosis. Ore Res. 77, 445−465 (1995). | ChemPort |
  14. Morishita, R. et al. Single intraluminal delivery of antisense cdc2 kinase and prolifer-ating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90, 8474−8478 (1993). | PubMed  | ChemPort |
  15. Mann, M. et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc. Natl. Acad. Sci. USA 92, 4502−4506 (1995). | PubMed  | ChemPort |
  16. Wagner, R.W. Gene inhibition using antisense oligonucleotides. Nature 372, 333−335 (1994). | Article | PubMed  | ISI | ChemPort |
  17. Burgess, T.L. et al. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92, 4051−4055 (1995). | PubMed  | ChemPort |
  18. Boise, L.H. et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597−608 (1993). | Article | PubMed  | ISI | ChemPort |
  19. Minn, A.J., Boise, L.H. & Thompson, C.B. Bcl-x(S) antagonizes the protective effects of Bcl-x(L). J. Biol. Chem. 271, 6306−6312 (1996). | Article | PubMed  | ISI | ChemPort |
  20. Faxon, D.P. et al. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis. Arteriosclerosis 2, 125−133 (1982). | PubMed  | ISI | ChemPort |
  21. Shinomiya, M., Shirai, K., Saito, Y. & Yoshida, S. Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol. Atherosclerosis 97, 143−148 (1992). | PubMed  | ISI | ChemPort |
  22. Morishita, R, et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 93, 1458−1464 (1994). | PubMed  | ISI | ChemPort |
  23. Pollman, M.J., Yamada, T., Horiuchi, M. & Gibbons, G.H. Vasoactive substances regulate vascular smooth muscle cell apoptosis: Countervailing influences of nitric oxide and angiotensin II. Circ. Res. 79, 748−756 (1996). | PubMed  | ISI | ChemPort |
  24. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493−501 (1992). | Article | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1998 Nature Publishing Group | Privacy policy